Related Experiment Video
Updated: Mar 7, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
5.3K
Decrease in use of contraindicated drugs with automated alerts in children
Inmyung Song1, Han Na Shin2, Ju-Young Shin3
1Division of Risk Assessment and International Cooperation, Korea Centers for Disease Control and Prevention, Cheongju, Korea.
Summary
Automated alerts significantly reduced contraindicated drug use in children. This regulatory action led to an 85.71% decrease in prescribing age-inappropriate medications.
Area of Science:
- Pediatric Pharmacology
- Drug Safety
- Health Informatics
Background:
- Evaluating pediatric drug safety is crucial.
- Automated alerts can improve medication safety.
- Nationwide drug utilization reviews are effective tools.
Purpose of the Study:
- To assess the impact of automated alerts on contraindicated drug prescriptions in pediatric patients.
- To analyze changes in drug utilization following regulatory action.
Main Methods:
- Interrupted time series analysis of nationwide health insurance data (2007-2011).
- Included 72 age-contraindicated drugs across 22 classes.
- Compared drug use before and after a December 2009 regulatory action.
Main Results:
- Prescription of age-contraindicated drugs decreased from 2.10% to 0.30%.
- This represents an 85.71% relative reduction in users.
- A gradual downward trend in monthly users was observed post-regulation.
Conclusions:
- Regulatory action with automated alerts effectively reduced contraindicated drug use in pediatrics.
- The study demonstrates the success of system-level interventions in improving pediatric drug safety.
More Related Videos
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
343
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
01:29Drug Dosing: Infants and Children
625
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
625
01:26Pharmaceutical Poisoning: Potential Scenarios
47
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
405
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
304
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
583
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
583